Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry aims to unlock secrets of nerve treatment for fainting disorders

NCT ID NCT07196397

Knowledge-focused Sponsor: SABAMED Medical Center Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a registry that collects information from 1,000 adults who have conditions like fainting, rapid heartbeat, or low blood pressure and have received a procedure that adjusts nerve signals to the heart. Researchers will track whether symptoms return within a year. The goal is to better understand how well these nerve-modulating procedures work over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult patients aged 18 years and older with documented autonomic cardiovascular dysfunction, referred for or previously treated with procedures targeting cardiac innervation. The population includes both men and women, and covers a broad clinical spectrum including IST, POTS, VVS, CSS, sinus bradycardia, and orthostatic hypotension. Participants are enrolled across multiple centers in Poland. The study includes both retrospective and prospective cohorts.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Diagnosis of at least one of the following conditions: * Inappropriate sinus tachycardia (IST) * Postural orthostatic tachycardia syndrome (POTS) * Vasovagal syncope (VVS) * Cardioinhibitory carotid sinus syndrome (CSS) * Symptomatic sinus bradycardia or functional AV block * Orthostatic hypotension (OH) * History of recurrent autonomic symptoms (e.g., syncope, bradycardia, palpitations, orthostatic intolerance) * Undergoing or previously underwent interventional treatment affecting cardiac autonomic innervation (e.g., cardioneuroablation, SN-sparing ablation, cardiac sympathetic denervation) * Provided written informed consent (for prospective arm) Exclusion Criteria: * Structural heart disease requiring surgical intervention * Permanent pacemaker or ICD implanted prior to enrollment * Inability to complete follow-up assessments or questionnaires * Severe psychiatric comorbidities impairing participation * Participation in another interventional clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autonomic diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrioventricular block autonomic nervous system disorder cardiac rhythm disease coronary microvascular disorder Hypotension, Orthostatic Microvascular Angina orthostatic hypotension postural orthostatic tachycardia syndrome primary dysautonomia Prinzmetal angina Raynaud disease Syncope syncope, familial vasovagal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autonomic diseases Autonomic dysfunction Cardioinhibitory carotid sinus syndrome CSS Inappropriate sinus tachycardia syndrome ist Microvascular angina Orthostatic hypotension Postural orthostatic tachycardia syndrome (POTS) Raynaud phenomena Symptomatic sinus bradycardia SB or atrioventricular block av Vasospastic angina Vasovagal syndrome VVS Ventricular arrythmia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • SabaMed

    RECRUITING

    Rzeszów, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.